Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06590532

Evaluation of the Clinical and Cost-effectiveness of an Automated Mobile Hybrid Room in Vascular Surgery Compared with Current Practice

Evaluation of the clinical and cost-effectiveness of a mobile hybrid room compared with current practice without mobile hybrid room and imaging fusion guidance, in a French multicentre clinical setting.

The hypothesis is that the use of a mobile hybrid room with an automated artificial intelligent image fusion system would directly benefit patients, health worker and health care system by reducing procedure time, patient and staff exposure to radiation, improve clinical success and reduce costs (requested by a fixed imaging system installation and increasing the number of patients). This will also improve the safety of these procedures for patient and staff, when a conventional hybrid room is not available

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rinckenbach, Besançon, France

Loading trial locations.

About this study

Multi-centre, patient- and observer-blinded, two-armed, parallel groups randomised controlled trial. 7 French University hospital will include 350 patients presenting with AAA or aorto iliac occlusive disease suitable for endovascular treatment, to either repair using standard X-ray fluoroscopy imaging alone (the current reference standard) or augmented with automated image fusion. The study will be conducted in real-world clinical settings and will focus on multiple providers to demonstrate the effect in the wider healthcare system.

The trial will be conducted in 7 centres in France over 24 months. 350 patients will be recruited over a 18 month period, with 3 months minimum follow-up. Every vascular surgeon will be trained to use properly the fusion system, and the first 5 patients of each center won't be included.

Radiation parameters (machine report, passive dosimeters), iodinated contrast, technical and clinical success at 30-d and 3 months, procedure time, fluoro time, and costs will be collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Procedure carried out in an operating theatre equipped with a mobile operating theatre C-arm or a mobile planar or an old-generation fixed room with no image fusion available
  • Surgeon trained in the use of image fusion
  • Operator who has given their consent
  • Endovascular management of an aorto-iliac artery disease or a sub-renal AAA using a sub-renal bifurcated stent graft
  • Patient in possession of an angioscan less than 6 months old
  • Patient of legal age who has given his/her consent
  • Ionising radiation generator with up-to-date and validated quality control
  • Participant affiliated to a Social Security scheme

Exclusion criteria

  • First procedure with fusion for the previously trained surgeon.
  • Procedure performed without an operating aid.
  • Emergency procedure.
  • Associated surgical procedure (femoropopliteal lesions, lesions of the renal or digestive arteries, iliac branch).

digestive arteries, iliac branch).

  • Patients with AAA that cannot be treated by a simple sub-renal endovascular approach simple endovascular approach (subrenal bifurcated stent graft)
  • Aortic emergencies (ruptured AAA).
  • Persons under guardianship, curatorship or safeguard of justice
  • Pregnant or breast-feeding women.

Treatment and study plan

Endovascular aneurysm repair or aorto iliac endovascular revascularisation with Fusion imaging system Cydar-EV

Procedure

Cydar-EV image fusion is a CE-marked medical device, which instead of a table-tacked overlay uses computer vision to fuse pre-procedural 3D images with intra-operative 2D fluoroscopy automatically and in real-time.

Endovascular aneurysm repair or aorto iliac endovascular revascularisation without Fusion imaging system Cydar-EV

Procedure

patients will be assigned either to an endovascular repair using standard X-ray fluoroscopy imaging alone (the current reference standard)

Primary outcomes

  1. Cost consequence analysis associated with endovascular procedures performed using automatic imaging fusion guidance and conventional endovascular technique performed without image fusion guidance up to 30 days time horizon and a collective perspective.

    Time frame: 18 month

    To compare the costs and consequences associated with endovascular procedures performed using automatic imaging fusion guidance and conventional endovascular technique performed without image fusion guidance. Consequences are listed in the secondary endpoints. Cos twill be express in €.

Secondary outcomes

  1. X-ray dose per procedure

    Time frame: day 0

    exposure parameters from the machine

  2. X-ray dose per procedure for the physician

    Time frame: day 0

    exposure parameters from the dosimeter

  3. Contrast dose per procedure

    Time frame: day 0

    Contrast dose used

  4. Length of ITU/HDU admission

    Time frame: 18 months

    Length of ITU/HDU admission

  5. Technical success

    Time frame: day 0

    defined as proximal and distal seal zone at least 10mm and no evidence of endoleak or revascularization success.

  6. Clinical success

    Time frame: 1 month

    defined as primary patency rate or endovascular exclusion of the aneurysm

  7. 30-day mortality

    Time frame: 30 days

    30-day mortality

  8. Quality of life questionnaire

    Time frame: 30 days

    EQ-5D-5L assessement

  9. cost-effectiveness

    Time frame: 5 years

    Net financial impact over 5 years of SHMA deployment (based on the 5-year projection and different different scenarios for the spread of the technology)

Study contacts

Contact information is provided by the study sponsor or research team.

Blandine Maurel, Pr

CONTACT

[email protected]

02 40 16 53 72

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

French Randomised Controlled Trial Investigating the Clinical and Cost-effectiveness Role of a Cloud-based, Artificial Intelligent Image Fusion System to Guide Endovascular Aortic Aneurysm Repair and Aorto Iliac Revascularisation.

Acronym: RADIOPROTEC

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Sep 19, 2024
Registry last updated
Dec 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.